Prostate cancer rates have increased over the past decade in the United States.
Prostate cancer rates are on the rise in the United States, especially in advanced-stage diagnoses. , which has led patients like Pablo Guillén and his two sons to join the American Cancer Society (ACS) in urging men to get screened early.
"This disease doesn't wait any longer; we shouldn't get complacent," says Guillén, 87, originally from Mexico.
After a fight against the disease for more than two decades, the Hispanic regrets that prostate cancer diagnoses increased by 3% annually between 2014 and 2021 in the United States, according to the ACS's annual prostate cancer statistics report.
In advanced-stage diagnoses, there was a greater increase of 4.6% to 4.8% annually.
READ: Ministry of Foreign Affairs monitors six Mexicans traveling to Gaza on the Sumud Global FlotillaThe increase came after cases had declined 6.4% annually over the previous decade.
Guillén's biggest concern, as he has lived in Texas for more than half a century, is that many men might be repeating his story, since he discovered his illness "by chance."
A routine checkup for eye surgery at the age of 63 led doctors to diagnose him with prostate cancer. "Many men feel embarrassed when it comes to getting tested; this is still a taboo we should have overcome by now," he says.
His fight against the disease, which included several rounds of chemotherapy and radiation, and an injection every three months for the past twenty years, made him aware of the importance of paying attention to prostate cancer, which he calls a "silent killer."
That painful process is what encouraged his sons, Jaime, 63, and Luis, 56, to follow his advice.
Jaime managed to detect the disease in time and was able to stop it with a less aggressive treatment than his father's , while Luis is in constant check-ups because he has already had problems.
"Before my dad's diagnosis I thought illnesses had to hurt, and that if it didn't hurt there was no need to consult a doctor, but that is a mistake," says Luis Guillén.
You might be interested in: Trump will renegotiate the trade pact with Mexico and Canada in October, the WSJ reports.In this regard, scientist Tyler Kratzer, lead author of the study, indicates that the results underscore the need to redouble efforts to understand the etiology of prostate cancer and optimize its early detection.
The researcher warns that, according to ACS guidelines, At age 50, all men should talk to their health care professional about the benefits and harms of screening tests. , but black men and those with a family history of prostate cancer "should do so at age 45."
Prostate cancer is the most common diagnosis among men in the United States, accounting for 30% of all male cancers in 2025 and the second leading cause of cancer death in men, after lung cancer.
Regarding Hispanics, Kratzer says the later diagnosis and lower survival rates among Hispanic men compared to whites "likely reflect less access to high-quality care," including screening and early detection, due to the disproportionate poverty they face.
Furthermore, the researcher indicates that survival rates among Hispanics are likely overestimated , due to the loss to follow-up of cases in this population.
This year, the ACS estimates there will be 313,780 new cases of prostate cancer in the country and 35,770 deaths.
*Stay up to date with the news, join our WhatsApp channel here: https://whatsapp.com/channel/0029VaAf9Pu9hXF1EJ561i03
MV
informador
